/term/loans-receivable/SHSE:688222 HitGen (SHSE:688222) Loans Receivable
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HitGen Inc (SHSE:688222) » Definitions » Loans Receivable

HitGen (SHSE:688222) Loans Receivable : ¥0.0 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is HitGen Loans Receivable?

HitGen's Loans Receivable for the quarter that ended in Mar. 2024 was ¥0.0 Mil.


HitGen Loans Receivable Historical Data

The historical data trend for HitGen's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HitGen Loans Receivable Chart

HitGen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial - - - - -

HitGen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

HitGen Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


HitGen Loans Receivable Related Terms

Thank you for viewing the detailed overview of HitGen's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


HitGen (SHSE:688222) Business Description

Traded in Other Exchanges
N/A
Address
No. 18, Section 2, Biocity Middle Road, Chengdu Tianfu International Biological City, Shuangliu District, Sichuan Province, Chengdu, CHN, 610093
HitGen Inc is engaged in drug research and development and provision of technical consultation, technology transfer, and technical services. The company uses DEL technology to provide research and development services for early drug discovery and transfer of new drug R&D projects.

HitGen (SHSE:688222) Headlines

No Headlines